Track Ovagen in Peptimes™
Ovagen is a peptide of three amino acids: Glu-Asp-Leu (glutamyl-aspartyl-leucine, EDL). The US National Library of Medicine's MeSH vocabulary lists this tripeptide. (Source: NLM MeSH.)
Is Ovagen FDA-approved?
No. Ovagen isn't FDA-approved: Drugs@FDA lists no application with Ovagen (Glu-Asp-Leu) as an active ingredient.
Ovagen
Also: EDL peptide, Glu-Asp-Leu, glutamyl-aspartyl-leucine
- Status label in the Peptimes Library
- Not FDA-Approved
- Routes in Peptimes
- OralSublingual
- Updated
- 1 Nov 2026
US regulatory status
What studies have looked at
Each point says who or what was studied and what the study reported, with its source and the date we checked it. These are findings from the sources cited, not advice or a promise of any result.
- In animals or the lab
In rats with drug-induced or blood-flow kidney injury, EDL prevented the fall in urine output and the build-up of nitrogen waste, and reduced protein loss in the urine. An animal study with its developers' group.
Source: PMID 28744634, checked 1 Nov 2026
- In animals or the lab
In rats with acute kidney failure caused by the cancer drug cisplatin, EDL given by itself normalised urine output and filtration and reduced protein in the urine. An animal study with its developers' group.
Source: PMID 26515176, checked 1 Nov 2026
How to track it in Peptimes
Add Ovagen in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”.
- Routes: oral or sublingual. Choose the one that matches each dose.
- Logging: the amount you took, the route and how you feel. Neither route has an injection site to record.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell Ovagen or any other compound.
More sources
- NLM, MeSH, glutamyl-aspartyl-leucine, checked 1 Nov 2026: the tripeptide, with the entry term Glu-Asp-Leu.
- Khavinson and colleagues, Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers and Peptide Regulation of Gene Expression: A Systematic Review, reviews from its developers’ group, read 1 Nov 2026: list Ovagen as the peptide EDL.
- FDA, Drugs@FDA, checked 1 Nov 2026: no application lists Ovagen or Glu-Asp-Leu as an active ingredient.
- NIH, ClinicalTrials.gov, studies of Ovagen, checked 1 Nov 2026: no registered study.